Skip to Content
  • オフィス

    オフィス

    北米・南米
    • Atlanta
    • Austin
    • Bogota
    • Boston
    • Buenos Aires
    • Chicago
    • Dallas
    • Denver
    • Houston
    • Los Angeles
    • Mexico City
    • Minneapolis
    • Monterrey
    • Montreal
    • New York
    • Rio de Janeiro
    • San Francisco
    • Santiago
    • São Paulo
    • Seattle
    • Silicon Valley
    • Toronto
    • Washington, DC
    ヨーロッパ・中東・アフリカ
    • Amsterdam
    • Athens
    • Berlin
    • Brussels
    • Copenhagen
    • Doha
    • Dubai
    • Dusseldorf
    • Frankfurt
    • Helsinki
    • Istanbul
    • Johannesburg
    • Kyiv
    • Lisbon
    • London
    • Madrid
    • Milan
    • Munich
    • Oslo
    • Paris
    • Riyadh
    • Rome
    • Stockholm
    • Vienna
    • Warsaw
    • Zurich
    アジア・オーストラリア
    • Bangkok
    • Beijing
    • Bengaluru
    • Brisbane
    • Ho Chi Minh City
    • Hong Kong
    • Jakarta
    • Kuala Lumpur
    • Manila
    • Melbourne
    • Mumbai
    • New Delhi
    • Perth
    • Shanghai
    • Singapore
    • Sydney
    • Tokyo
    全てのオフィス
  • アルムナイ
  • メディア
  • お問い合わせ
  • 東京オフィス
  • Japan | 日本語

    地域と言語を選択

    グローバル
    • Global (English)
    北米・南米
    • Brazil (Português)
    • Argentina (Español)
    • Canada (Français)
    • Chile (Español)
    • Colombia (Español)
    ヨーロッパ・中東・アフリカ
    • France (Français)
    • DACH Region (Deutsch)
    • Italy (Italiano)
    • Spain (Español)
    • Greece (Elliniká)
    アジア・オーストラリア
    • China (中文版)
    • Korea (한국어)
    • Japan (日本語)
  • Saved items (0)
    Saved items (0)

    You have no saved items.

    後で閲読、共有できるようにするためにブックマークしてください

    Explore Bain Insights
  • 業界別プラクティス
    メインメニュー

    業界別プラクティス

    • 航空宇宙、防衛、政府関連
    • 農業
    • 化学製品
    • インフラ、建設
    • 消費財
    • 金融サービス
    • ヘルスケア
    • 産業機械、設備
    • メディア、エンターテインメント
    • 金属
    • 採掘・鉱業
    • 石油、ガス
    • 紙、パッケージ
    • プライベートエクイティ
    • 公共、社会セクター
    • 小売
    • テクノロジー
    • 通信
    • 交通
    • 観光産業
    • 公益事業、再生可能エネルギー
  • 機能別プラクティス
    メインメニュー

    機能別プラクティス

    • カスタマー・エクスペリエンス
    • サステイナビリティ、 社会貢献
    • Innovation
    • 企業買収、合併 (M&A)
    • オペレーション
    • 組織
    • プライベートエクイティ
    • マーケティング・営業
    • 戦略
    • アドバンスド・アナリティクス
    • Technology
    • フルポテンシャル・トランスフォーメーション
  • Digital
  • 知見/レポート
  • ベイン・アンド・カンパニーについて
    メインメニュー

    ベイン・アンド・カンパニーについて

    • ベインの信条
    • 活動内容
    • 社員とリーダーシップ
    • プレス・メディア情報
    • クライアントの結果
    • 受賞歴
    • パートナーシップを結んでいる団体
    Further: Our global responsibility
    • ダイバーシティ
    • 社会貢献
    • サステイナビリティへの取り組み
    • 世界経済フォーラム(WEF)
    Learn more about Further
  • キャリア
    メインメニュー

    キャリア

    • ベインで働く
      キャリア
      ベインで働く
      • Find Your Place
      • ベインで活躍する機会
      • ベインのチーム体制
      • 学生向けページ
      • インターンシップ
      • 採用イベント
    • ベインでの体験
      キャリア
      ベインでの体験
      • Blog: Inside Bain
      • キャリアストーリー
      • 社員紹介
      • Where We Work
      • 成長を後押しするサポート体制
      • アフィニティ・グループ
      • 福利厚生
    • Impact Stories
    • 採用情報
      キャリア
      採用情報
      • 採用プロセス
      • 面接内容
    FIND JOBS
  • オフィス
    メインメニュー

    オフィス

    • 北米・南米
      オフィス
      北米・南米
      • Atlanta
      • Austin
      • Bogota
      • Boston
      • Buenos Aires
      • Chicago
      • Dallas
      • Denver
      • Houston
      • Los Angeles
      • Mexico City
      • Minneapolis
      • Monterrey
      • Montreal
      • New York
      • Rio de Janeiro
      • San Francisco
      • Santiago
      • São Paulo
      • Seattle
      • Silicon Valley
      • Toronto
      • Washington, DC
    • ヨーロッパ・中東・アフリカ
      オフィス
      ヨーロッパ・中東・アフリカ
      • Amsterdam
      • Athens
      • Berlin
      • Brussels
      • Copenhagen
      • Doha
      • Dubai
      • Dusseldorf
      • Frankfurt
      • Helsinki
      • Istanbul
      • Johannesburg
      • Kyiv
      • Lisbon
      • London
      • Madrid
      • Milan
      • Munich
      • Oslo
      • Paris
      • Riyadh
      • Rome
      • Stockholm
      • Vienna
      • Warsaw
      • Zurich
    • アジア・オーストラリア
      オフィス
      アジア・オーストラリア
      • Bangkok
      • Beijing
      • Bengaluru
      • Brisbane
      • Ho Chi Minh City
      • Hong Kong
      • Jakarta
      • Kuala Lumpur
      • Manila
      • Melbourne
      • Mumbai
      • New Delhi
      • Perth
      • Shanghai
      • Singapore
      • Sydney
      • Tokyo
    全てのオフィス
  • アルムナイ
  • メディア
  • お問い合わせ
  • 東京オフィス
  • Japan | 日本語
    メインメニュー

    地域と言語を選択

    • グローバル
      地域と言語を選択
      グローバル
      • Global (English)
    • 北米・南米
      地域と言語を選択
      北米・南米
      • Brazil (Português)
      • Argentina (Español)
      • Canada (Français)
      • Chile (Español)
      • Colombia (Español)
    • ヨーロッパ・中東・アフリカ
      地域と言語を選択
      ヨーロッパ・中東・アフリカ
      • France (Français)
      • DACH Region (Deutsch)
      • Italy (Italiano)
      • Spain (Español)
      • Greece (Elliniká)
    • アジア・オーストラリア
      地域と言語を選択
      アジア・オーストラリア
      • China (中文版)
      • Korea (한국어)
      • Japan (日本語)
  • Saved items  (0)
    メインメニュー
    Saved items (0)

    You have no saved items.

    後で閲読、共有できるようにするためにブックマークしてください

    Explore Bain Insights
  • 業界別プラクティス
    • 業界別プラクティス

      • 航空宇宙、防衛、政府関連
      • 農業
      • 化学製品
      • インフラ、建設
      • 消費財
      • 金融サービス
      • ヘルスケア
      • 産業機械、設備
      • メディア、エンターテインメント
      • 金属
      • 採掘・鉱業
      • 石油、ガス
      • 紙、パッケージ
      • プライベートエクイティ
      • 公共、社会セクター
      • 小売
      • テクノロジー
      • 通信
      • 交通
      • 観光産業
      • 公益事業、再生可能エネルギー
  • 機能別プラクティス
    • 機能別プラクティス

      • カスタマー・エクスペリエンス
      • サステイナビリティ、 社会貢献
      • Innovation
      • 企業買収、合併 (M&A)
      • オペレーション
      • 組織
      • プライベートエクイティ
      • マーケティング・営業
      • 戦略
      • アドバンスド・アナリティクス
      • Technology
      • フルポテンシャル・トランスフォーメーション
  • Digital
  • 知見/レポート
  • ベイン・アンド・カンパニーについて
    • ベイン・アンド・カンパニーについて

      • ベインの信条
      • 活動内容
      • 社員とリーダーシップ
      • プレス・メディア情報
      • クライアントの結果
      • 受賞歴
      • パートナーシップを結んでいる団体
      Further: Our global responsibility
      • ダイバーシティ
      • 社会貢献
      • サステイナビリティへの取り組み
      • 世界経済フォーラム(WEF)
      Learn more about Further
  • キャリア
    人気検索キーワード
    • デジタル
    • 戦略
    前回の検索
      最近訪れたページ

      Content added to saved items

      Saved items (0)

      Removed from saved items

      Saved items (0)

      インタラクティブ

      Digital health: A day in the life of a clinical investigator

      Technology can improve drug trial participation rates, monitor compliance and reduce costly drop-outs, while speeding regulatory decisions and new trial launches.

      著者:Patrick O'Hagan

      インタラクティブ

      Digital health: A day in the life of a clinical investigator
      en

      In this audio presentation, Bain partner Patrick O'Hagan discusses how digital health technologies will affect the life of a clinical investigator. 


      play-presentation-button


      Digital health won’t just transform the back office. It will change the daily lives of people throughout the healthcare system—from doctors, nurses and clinical investigators to patients, including both the seriously ill and the very healthy. 


      Presentation transcript: A day in the life of a clinical investigator

      Slide 1. Digital health: Clinical investigator

      Hi. I’m Patrick O’Hagan. I’m a partner in our Healthcare practice based in the Boston office, and I just want to take a few minutes to talk to you about digital health and its transformational impact on clinical investigators.

      Slide 2. The busy life of a clinical investigator

      What’s unique for investigators is that they have a very busy life. What they’re doing is balancing care, both for their patients, who participate in their daily practice, but also the patients who are participating in clinical trials. As a result of that, they’re doing a lot of juggling and bouncing back and forth in the delivery of care throughout the day. So today, we’re going to talk about how digital health can help that investigator better balance their time and deliver care in a more high-impact and efficient manner.

      Slide 3. A day in the life of the clinical trials investigator

      Let’s start by taking a look at a day in the life of the clinical trials investigator. Now, no two days are the same for an investigator, but what follows is a reasonable description of what a day in the life might look like. And what you’ll notice is that digital health can have a transformational impact on that day. For example, remote monitoring allows the investigator to learn information about their patients in the trail and communicate with them, as well as potentially the hospital and the investigational review board—even the regulatory bodies, as needed, if there were adverse events. Other technologies can come into play. For example, videoconferencing and email. All of these digital health technologies allow the investigator to get their work done faster and in a more high-quality way and actually fit that activity into a very tight schedule, where they’re also seeing their patients in their practice. That gives you an overview of how digital health impacts their day. Let’s dive deeper now into each of these aspects and see how it plays out.

      Slide 4. Remote monitoring of trial participants

      Let’s start by looking at the morning for the investigator. The investigator might grab a cup of coffee; remote monitoring allows the investigator to look at report on their individual patients in the trial. They might also access a social media feed and see what issues are trending in that trial. The combination of this information could allow them to identify issues early. For example, if motivation or other concerns are being flagged on the trial, they potentially then can intervene early, proactively, and reduce dropout rates in the trail, saving up to $6,000 per dropout.

      Slide 5. Communicates trials data with IRB and FDA

      In turn, the investigator—in this case, Dr. John—can leverage the power of data mining to access information about their patients. For example, he might find that an adverse event has occurred and then quickly report this information to the IRB as well as to the FDA. Or, in the case of his running an oncology trial, he might pull up and share interim data from that trial with the FDA. In these cases, the power of data mining is allowing Dr. John to capture the information and report it more quickly, thus increasing the rate of reporting on that adverse event, for example, and speeding the time to decision making by the IRB and the FDA.

      Slide 6. Sends targeted educational materials

      We all know that marketers are using digital technology today to segment their customers and deliver highly tailored information. In healthcare, it will end up being no different. So, in this case, Dr. John can use digital health technology to segment his patient population to send information to patients in the appropriate age group or to patients, for example, who are not complying with the trial and help motivate them to participate at the appropriate level. Or he might try a new message on a sample of patients to gauge their reaction, refine the message and distribute it to a whole population of patients.

      Slide 7. Collaboration with other investigators

      One of the challenges of the clinical trial is that it’s spread across multiple sites. Today, already in our business lives and personal lives, we’re using digital technology to communicate with colleagues and friends and family. In the future, healthcare will be the same. The investigator can collaborate with his colleagues through videoconferencing and real-time collaboration where they look at data and identify trends and work together to find solutions through the trial.

      Slide 8. Video chat with trial participant

      Just as Dr. John uses his videoconferencing to collaborate with his colleagues, he can also engage more directly and personally with his patients. In this case, the patient is wearing a remote monitor, and the algorithm identifies a potential issue and flags it for Dr. John. For videoconferencing, Dr. John talks with the patient, better understands the issue and analyzes the real-time data. He is actually able to resolve it remotely. As a result, this technology has save the time and the hardship for that patient of having to come into the hospital and do a visit live with Dr. John.

      Slide 9. Checks on potentially non-compliant participants

      Unlike the prior patient, who was highly engaged in the trial, Dr. John also struggles with the issue of patients who are non-compliant. Here, again, digital technology can help. For example, the pill bottle connected to the Internet can alert Dr. John on his phone that the patient has actually not opened and taken his pill. In this case, Dr. John can actually follow up with the patient, alert him about the non-compliance, and even a nurse can do a follow-up video chat a couple of hours later if the problem hasn’t been resolved. This can result in significant improvement in adherence to the clinical trial, potentially going from 50% up to as high as 95%.

      Slide 10. Signs on as investigator for new project

      Finally, Dr. John closes his day by conducting an online meeting with a sponsor for a new trial, who identified him through a physician social network. Once he is signed up, the sponsor sends information on potential participants it has identified through social networks, advocacy groups and payers.

      Slide 11. By 2020, digital health will have cut costs and increased innovation

      So digital health can greatly improve life for Dr. John as well as lower the costs and improve the quality of clinical trials. For example, it can lead to efficiency improvements, marked by a 65% reduction in time to recruit patients, it can improve the quality and availability of clinical data, and it can lead to much greater consumer engagement. For example, resulting in significant reduction in dropout rates for trial participants.

      Slide 12. Contact us

      If you’d like to learn more about how digital health can improve your healthcare business, please don’t hesitate to contact me or any of my colleagues in Bain & Company’s Healthcare practice. Thanks for listening.

      関連業種
      • ヘルスケア
      ヘルスケア
      Life Sciences’ AI Momentum Requires a Workforce Redesign

      AI scalers aren't waiting for new talent—they're building it.

      詳細
      ヘルスケア
      Accelerating Growth and Innovation in European Mid-Sized Pharma

      Insights from the last decade of growth and portfolio innovation can help crack the growth code for EU mid-size pharma.

      詳細
      ヘルスケア
      How Life Sciences Leaders Are Widening the AI Capability Gap

      Most pharma and medtech companies agree that a strong data foundation is table stakes. Few invest equally in the behaviors needed to move from pilots to adoption.

      詳細
      ヘルスケア
      From Silos to Pods: Scaling AI in Life Sciences

      Cross-functional collaboration is the real differentiator between those that see meaningful returns and those that don’t.

      詳細
      ヘルスケア
      Medtech M&A

      As leaders refocus portfolios, dealmaking officially returns.

      詳細
      First published in 6月 2012
      Tags
      • ヘルスケア

      クライアント支援事例

      サポート部門 Taking Shared Services to a New Level at a Healthcare Company

      ケーススタディを見る

      業績改善 Turning bottlenecks into growth opportunities

      ケーススタディを見る

      オペレーション Full-potential prescription makes pharmacy client better

      ケーススタディを見る

      お気軽にご連絡下さい

      私達は、グローバルに活躍する経営者が抱える最重要経営課題に対して、厳しい競争環境の中でも成長し続け、「結果」を出すために支援しています。

      ベインの知見。競争が激化するグローバルビジネス環境で、日々直面するであろう問題について論じている知見を毎月お届けします。

      *プライバシーポリシーの内容を確認し、合意しました。

      プライバシーポリシーをご確認頂き、合意頂けますようお願い致します。
      Bain & Company
      お問い合わせ Sustainability Accessibility Terms of use Privacy Cookie Policy Sitemap Log In

      © 1996-2026 Bain & Company, Inc.

      お問い合わせ

      How can we help you?

      • ビジネスについて
      • プレス報道について
      • 採用について
      全てのオフィス